drugset / Trial / NCT03328832

Combined Topical Tranexamic Acid With Floseal® in Total Knee Arthroplasty

NCT03328832

Phase 4 Completed 70 enrolled Chang Gung Memorial Hospital
RandomizedParallel-groupSingle-blindPrevention

Summary

Our purpose of this study therefore is to conduct a prospective randomized controlled trial to investigate the blood-conservation effect of combined topical application of these two hemostatic agents in different time during surgery and the safety compared with single topical application of TKA in a primary TKA procedure

Timeline

Start
2017-09-12
Primary completion
2018-09-30
Completion
2018-12-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Floseal Other / unclassified 10 ml Topical
Comparator Rivaroxaban Other / unclassified 10 mg Oral
Comparator Tranexamic Acid Small molecule 3 g Other

Indications